 |
Indium In-111 altumomab pentetate |
|---|---|
| Trade Name | Hybri-Ceaker |
| Orphan Indication | Detection of suspected and previously unidentified tumor foci of recurrent colorectal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1990-02-06 00:00:00 |
| Sponsor | Hybritech, Inc.;11095 Torreyanna Road;San Diego, California, 92196 |
